Literature DB >> 21335561

Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection.

Steven Hatch1, Tim P Endy, Stephen Thomas, Anuja Mathew, James Potts, Pamela Pazoles, Daniel H Libraty, Robert Gibbons, Alan L Rothman.   

Abstract

The pathophysiology of dengue virus infection remains poorly understood, although secondary infection is strongly associated with more severe disease. In the present study, we performed a nested, case-control study comparing the responses of pre-illness peripheral blood mononuclear cells between children who would subsequently develop either subclinical or symptomatic secondary infection 6-11 months after the baseline blood samples were obtained and frozen. We analyzed intracellular cytokine production by CD4(+) and CD8(+) cells in response to stimulation with dengue antigen. We found higher frequencies of dengue virus-specific TNFα, IFNγ-, and IL-2-producing T cells among schoolchildren who subsequently developed subclinical infection, compared with those who developed symptomatic secondary dengue virus infection. Although other studies have correlated immune responses during secondary infection with severity of disease, to our knowledge this is the first study to demonstrate a pre-infection dengue-specific immune response that correlates specifically with a subclinical secondary infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335561      PMCID: PMC3069729          DOI: 10.1093/infdis/jir012

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Dengue.

Authors:  A Kroeger; M Nathan; J Hombach
Journal:  Nat Rev Microbiol       Date:  2004-05       Impact factor: 60.633

2.  HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

Authors:  H A F Stephens; R Klaythong; M Sirikong; D W Vaughn; S Green; S Kalayanarooj; T P Endy; D H Libraty; A Nisalak; B L Innis; A L Rothman; F A Ennis; D Chandanayingyong
Journal:  Tissue Antigens       Date:  2002-10

3.  Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever.

Authors:  A S Mustafa; E A Elbishbishi; R Agarwal; U C Chaturvedi
Journal:  FEMS Immunol Med Microbiol       Date:  2001-04

4.  Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests.

Authors:  Y Okuno; T Fukunaga; S Srisupaluck; P Kasemsarn; C Dharakul; N Sangkawibha
Journal:  Biken J       Date:  1980-09

Review 5.  Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges.

Authors:  María G Guzman; Gustavo Kouri
Journal:  J Clin Virol       Date:  2003-05       Impact factor: 3.168

6.  Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining.

Authors:  Marlou M Mangada; Francis A Ennis; Alan L Rothman
Journal:  J Immunol Methods       Date:  2004-01       Impact factor: 2.303

7.  Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand.

Authors:  Timothy P Endy; Supamit Chunsuttiwat; Ananda Nisalak; Daniel H Libraty; Sharone Green; Alan L Rothman; David W Vaughn; Francis A Ennis
Journal:  Am J Epidemiol       Date:  2002-07-01       Impact factor: 4.897

8.  Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.

Authors:  Timothy P Endy; Ananda Nisalak; Supamit Chunsuttitwat; David W Vaughn; Sharone Green; Francis A Ennis; Alan L Rothman; Daniel H Libraty
Journal:  J Infect Dis       Date:  2004-03-01       Impact factor: 5.226

9.  Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren.

Authors:  Marlou M Mangada; Timothy P Endy; Ananda Nisalak; Supamit Chunsuttiwat; David W Vaughn; Daniel H Libraty; Sharone Green; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

Review 10.  Microevolution and virulence of dengue viruses.

Authors:  Rebeca Rico-Hesse
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

View more
  66 in total

1.  Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.

Authors:  Joseph D Comber; Aykan Karabudak; Xiaofang Huang; Paolo A Piazza; Ernesto T A Marques; Ramila Philip
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection.

Authors:  Hui-Mei Hu; Hsin-Wei Chen; Yu-Ju Hsiao; Szu-Hsien Wu; Han-Hsuan Chung; Chun-Hsiang Hsieh; Pele Chong; Chih-Hsiang Leng; Chien-Hsiung Pan
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 3.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 4.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

5.  Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles.

Authors:  Yuan Tian; Mariana Babor; Jerome Lane; Grégory Seumois; Shu Liang; N D Suraj Goonawardhana; Aruna D De Silva; Elizabeth J Phillips; Simon A Mallal; Ricardo da Silva Antunes; Alba Grifoni; Pandurangan Vijayanand; Daniela Weiskopf; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

6.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

Review 7.  T Cell Immunity to Zika and Dengue Viral Infections.

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  J Interferon Cytokine Res       Date:  2017-11       Impact factor: 2.607

8.  Prospects for a dengue vaccine: progress and pitfalls.

Authors:  Sarah L George
Journal:  Mo Med       Date:  2014 Jul-Aug

Review 9.  Dengue: knowledge gaps, unmet needs, and research priorities.

Authors:  Leah C Katzelnick; Josefina Coloma; Eva Harris
Journal:  Lancet Infect Dis       Date:  2017-02-07       Impact factor: 25.071

10.  CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.

Authors:  Raphaël M Zellweger; William W Tang; William E Eddy; Kevin King; Marisa C Sanchez; Sujan Shresta
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.